Genetics and Toxicology in Cancer Chemotherapy and Forensic Sciences

My research is focused on finding predictive markers and understanding how pharmaceutiacls and drugs yield desired and undesired effects in humans.

Everyone is different and everyone reacts differently to drugs. Our research group studies how genetic variation affects the effect and risk of side effects in cancer treatment. We also work with new psychoactive drugs (internet drugs), their toxicology and pharmacology. Our third track is genetics in a forensic perspective.

PublicationsShow/Hide content


NewsShow/Hide content

ResearchShow/Hide content

PublicationsShow/Hide content

Latest publications


About meShow/Hide content



  • Research strategist / Molecular Biologist in Engineering and Genomics. Department of Forensic Genetics and Forensic Toxicology, National Board of Forensic Medicine, Linköping. 
  • Associate Professor at Division of Drug Research, Department of Medical and Health Sciences, Faculty of Medical Sciences, Linköping University. 

  • 2011--2012. Post-doc at Science for Life Laboratory, Division of Gene technology, Institution for Biotechnology, KTH - Royal Institute of Technology. 
  • 2007 - 2012. Assistant Professor at the Division of Drug Research, Linköping University, Linköping Sweden.


  • 2000 - Master of Science in Engineering Biology. Institute of Technology, Linköping University, Linköping, Sweden.    
  • 2007 - PhD in Clinical Pharmacology. Division of Clinical Pharmacology, Department of medicine and Care, Faculty of Health Sciences, Linköping University, Linköping, Sweden. 
  • 2012 - Associate Professor in Pharmacogenetics at Linköping University.

Co-workersShow/Hide content

OrganisationShow/Hide content